Zacks Investment Research upgraded shares of Reckitt Benckiser Group PLC (OTCMKTS:RBGLY) from a sell rating to a buy rating in a report released on Wednesday morning. Zacks Investment Research currently has $21.00 target price on the stock.

According to Zacks, “Reckitt Benckiser Group Plc engages in manufacturing and distributing household, toiletry, pharmaceutical and food products. The company offers antiseptic liquids, depilatory products, medicated sore throat products, condoms, cold/flu products, acne treatment products, analgesics and upper gastro-intestinal products, foot care and comfort footwear products, denture care and dry skin care products, fabric care products, surface care products and polishes/waxes. Reckitt Benckiser Group is based in Slough, the United Kingdom. “

Several other equities analysts have also commented on RBGLY. Societe Generale restated a hold rating on shares of Reckitt Benckiser Group PLC in a research report on Thursday, June 22nd. Jefferies Group LLC lowered shares of Reckitt Benckiser Group PLC from a buy rating to a hold rating in a research report on Thursday, July 6th. Kepler Capital Markets lowered shares of Reckitt Benckiser Group PLC from a buy rating to a hold rating in a research report on Wednesday, July 26th. BNP Paribas restated a neutral rating on shares of Reckitt Benckiser Group PLC in a research report on Tuesday, September 5th. Finally, J P Morgan Chase & Co restated a neutral rating on shares of Reckitt Benckiser Group PLC in a research report on Thursday, September 7th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and two have given a buy rating to the company’s stock. The company presently has a consensus rating of Hold and a consensus price target of $21.00.

Shares of Reckitt Benckiser Group PLC (OTCMKTS:RBGLY) opened at 18.61 on Wednesday. The company has a 50 day moving average of $19.28 and a 200 day moving average of $19.49. Reckitt Benckiser Group PLC has a 52 week low of $16.36 and a 52 week high of $21.55. The firm has a market cap of $65.46 billion, a PE ratio of 27.69 and a beta of 0.86.

COPYRIGHT VIOLATION NOTICE: This news story was first published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this news story on another website, it was illegally stolen and reposted in violation of United States & international trademark and copyright law. The legal version of this news story can be viewed at https://www.thecerbatgem.com/2017/10/01/reckitt-benckiser-group-plc-rbgly-rating-increased-to-buy-at-zacks-investment-research.html.

The business also recently announced a None dividend, which will be paid on Thursday, October 5th. Investors of record on Friday, August 18th will be given a $0.163 dividend. The ex-dividend date of this dividend is Wednesday, August 16th.

Reckitt Benckiser Group PLC Company Profile

Reckitt Benckiser Group plc is a manufacturer and marketer of health, hygiene and home products. The Company’s segments include ENA and DvM. The ENA segment consists of Europe, Russia/Commonwealth of Independent States (CIS), Israel, North America, Australia and New Zealand. The DvM segment consists of North Africa, Middle East (excluding Israel) and Turkey, Africa, South Asia, North Asia, Latin America, Japan, Korea and the Association of Southeast Asian Nations (ASEAN).

Get a free copy of the Zacks research report on Reckitt Benckiser Group PLC (RBGLY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Reckitt Benckiser Group PLC (OTCMKTS:RBGLY)

Receive News & Stock Ratings for Reckitt Benckiser Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group PLC and related stocks with our FREE daily email newsletter.